BRCA1 as Target for Breast Cancer Prevention and Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|15|1|4-14

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.15, Iss.1, 2015-01, pp. : 4-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy

By Pierce Lori  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 389-398

Springer Publishing Company

Access to resources Recommend Favorite

BRCA1 and BRCA2 in breast cancer

By Yang X.   Lippman M.E.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 1, 1999-03 ,pp. : 1-10

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

By Reding Kerryn  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 491-498

Springer Publishing Company

Access to resources Recommend Favorite

Can the Status of the Breast and Ovarian Cancer Susceptibility Gene 1 Product (BRCA1) Predict Response to Taxane-Based Cancer Therapy?

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 5, 2009-06 ,pp. : 543-549

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic therapy options in BRCA mutation-associated breast cancer

By Bayraktar Soley  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 355-366

Springer Publishing Company

Access to resources Recommend Favorite